MM&M Women of Distinction Honoree
Co-founder and CEO of Greater Than One, Elizabeth Apelles, has been named one of MM&M’s Women of Distinction. As a rare disease advocate and diversity champion, Apelles inspires employees and clients alike with her people-first approach to agency operations.
Diversity Q&A: Elizabeth Apelles, Greater Than One
Elizabeth Apelles, CEO of the Greater Than One (GTO) Group, discusses GTO’s commitment to diversity, equality and inclusion and explains why “diversity needs to be integral to any organization if they are to be successful.” Find out the transformative power of diversity in this exclusive, on-demand Q&A.
Honeycomb Health Receives Huge Honor
GTO Greater Good’s own Honeycomb Health, a nonprofit subsidiary has been named on the Top 8 That Innovate. Read about how Honeycomb Health’s mission to help people living with a rare disease and manage their health is not just making a much-needed difference, but also making award shortlists.
Digital Transformation in Pharma
Greater Than One (GTO) Group Chief Technology Officer Ken Winell joins a Crownpeak panel to discuss the ongoing transformation in healthcare marketing. All in this exclusive, on-demand webinar.
Putting rare on the map
In celebration of 10 years as a SCAD survivor, Honeycomb Health (HH) co-founder is going on a 10,000-mile cross-country road trip. Read about her tireless efforts to secure information management for rare disease patients everywhere, and discover ways that you can help grow the HH hive of support.
GTO Named MM+M Top 100 Agency
In acknowledging Greater Than One (GTO) as a premiere healthcare agency of 2021, Medical Marketing and Media (MM+M) recognized that our unique integration of data, content, media, and technology makes us truly greater than the sum of our parts.
OXLUMO® (lumasiran) Launch wins ELITE 2021 Award
Greater Than One (GTO) has been recognized by PM360 for its success in conceiving and launching a virtual campaign to support OXLUMO® (lumasiran), a first-in-class therapy developed by Alnylam.
Honeycomb Health Modernizes Rare Disease Management
Chief Executive Officer and Honeycomb Health (HH) co-founder Elizabeth Apelles discusses why the high-tech nonprofit will forever change the lives of rare disease patients everywhere, and shares the buzz about her co-founder’s road trip to raise $3M dollars.
Digital transformation panel discussion
Chief Technology Officer Ken Winell joins a panel of industry experts to discuss audience demands for novel experiences, the challenges posed by increasing regulation, and technology solutions that can help set marketers up for success.
Introducing RESONIC™
Soliton and GTO joined forces in September 2020 to help launch the revolutionary RESONIC Rapid Acoustic Pulse™ (RAP) device and establish Soliton as a leader in the aesthetics industry. Today, we are beyond proud to announce the work we have done for RESONIC.